PUBLIC RELEASE DATE:
16-Apr-2014
Contact: Sarah Cavanaugh scavanaugh@celldex.com 508-864-8337 Celldex Therapeutics
HAMPTON, NJ (April 16, 2014): Celldex Therapeutics, Inc. (NASDAQ: CLDX) announced today that final data from its Phase 1 study of CDX-1401 in solid tumors, including long-term patient follow-up, have been published in Science Translational Medicine (Vol 6 Issue 232). The data demonstrate robust antibody and T cell responses and evidence of clinical benefit in patients with very advanced cancers and suggest that CDX-1401 may predispose patients to better outcomes on subsequent therapy with checkpoint inhibitors. CDX-1401 is an off-the-shelf vaccine consisting of a fully human monoclonal antibody with specificity for the dendritic cell receptor DEC-205 linked to the NY-ESO-1 tumor antigen. The vaccine is designed to activate the patient's immune system against cancers that express the tumor marker NY-ESO-1. While the function of NY-ESO-1 continues to be explored, references in the literature suggest that its expression might reflect the acquisition of properties that cancers find useful, such as immortality, self-renewal, migratory ability and the capacity to invade.
The Phase 1 study of CDX-1401 is the first clinical study to demonstrate that an off-the-shelf vaccine that targets dendritic cells in vivo through DEC-205 can safely lead to robust humoral and cellular immunityovercoming a significant challenge in the development of protein based vaccines. Targeting protein antigens to the DEC-205 receptor on dendritic cells was pioneered by the late Ralph Steinman, MD, a member of Celldex's Scientific Advisory Board. Dr. Steinman received the 2011 Nobel Prize in Physiology or Medicine for his discovery of the dendritic cell and its role in adaptive immunity. This now-proven ability to target proteins, like NY-ESO-1, to dendritic cells to generate potent immune responses specific to these proteins represents a promising approach for the next generation of vaccines against pathogens and cancer.
"CDX-1401 offers a novel, well-tolerated and practical approach to generating protein specific immunity that can be readily combined with other treatment strategies to boost immunity against pathogens and tumors," said Dr. Madhav Dhodapkar, MBBS, Arthur H. and Isabel Bunker Professor of Medicine and Immunobiology, Chief of the Section of Hematology at the Department of Internal Medicine and Clinical Research Program Leader of the Hematology Program at Yale Cancer Center and lead author of the paper. "The preliminary findings in patients who received therapy with a checkpoint inhibitor following the vaccine provide further rationale for combination immunotherapy strategies, meriting further investigation."
Thomas Davis, MD, Senior Vice President and Chief Medical Officer of Celldex Therapeutics added, "CDX-1401 has overcome a significant historical challenge in the development of protein based vaccines by successfully targeting dendritic cells in vivo. It now sits at the forefront of a new generation of off-the-shelf dendritic cell targeted vaccines that we believe hold significant promise. Based on the results observed in this Phase 1 study, we expect CDX-1401 to enter at least two combination studies this year with both our own investigational therapies and external therapies in melanoma and other indications where we believe a dendritic cell vaccine regimen could play an important role." Initial results from the Phase 1 study of CDX-1401 were presented at the 2012 Society for Immunotherapy Annual Meeting. The manuscript published today expands upon this data and includes longer-term patient follow up.
CDX-1401 Phase 1 Study Overview and Results
The study was designed to assess the safety, immunogenicity and clinical activity of escalating doses of CDX-1401 with TLR agonists (resiquimod and/or Poly ICLC (HiltonolTM) in 45 patients with advanced malignancies refractory to all available therapies. CDX-1401 was well tolerated, with no dose limiting or grade 3 toxicities reported. The most frequently reported adverse events were administration site reaction, fatigue, nausea and chills. Treatment induced humoral and cellular immunity to NY-ESO-1 in patients with NY-ESO-1 expressing tumors across various dose levels and adjuvant combinations.
Significant anti-NY-ESO-1 titers occurred in 79% (33/42) of evaluable patients, with high titers (>1:10,000) in 52% and very high titers (>1:100,000) in 33% of patients. Similarly strong humoral immunity developed in each cohort and in patients with or without confirmed NY-ESO-1 expression in their tumor. Approximately 54% of patients with NY-ESO-1 positive tumors had anti-NY-ESO-1 titers at baseline and most increased after vaccination. NY-ESO-1-specific T cell responses were absent or low at baseline, but increased post-vaccination in 56% of evaluable patients, including both CD4 and/or CD8 T cell responses. Durability of the T cell response was demonstrated in two patients from whom samples from additional cycles of CDX-1401 treatment were available. In these patients, the induction of NY-ESO-1 specific T cells was maintained through three cycles (approximately seven months) of treatment.
Original post:
Celldex's Phase 1 study of CDX-1401 published in Science Translational Medicine
- Vet-Stem Medistem Cellmedicine Rheumatoid Arthritis Stem Cell Video.mp4 - March 23rd, 2011 [March 23rd, 2011]
- Holly Huber on Recovery: Stem Cell Therapy for Multiple Sclerosis Community Outreach Dallas, TX 2011 - March 26th, 2011 [March 26th, 2011]
- Macular Degeneration Improved With Stem Cells - March 31st, 2011 [March 31st, 2011]
- The Stem Cell Institute - April 2nd, 2011 [April 2nd, 2011]
- Cells That Heal Us From Cradle To Grave: A Quantum Leap in Medical Science - April 7th, 2011 [April 7th, 2011]
- Stem Cell Treatment Doing Wonders For Autistic Boy - April 9th, 2011 [April 9th, 2011]
- Explore Health Don Margolis part1 - April 15th, 2011 [April 15th, 2011]
- Explore Health Carlos Lima - One Step at a Time - May 19th, 2011 [May 19th, 2011]
- Stem Cell Patient Richard H. MS Treatment - May 20th, 2011 [May 20th, 2011]
- Visions Episode 92: Stem Cells Discovery - May 20th, 2011 [May 20th, 2011]
- Chemistry Tutorial 12.2c: Voltaic Cells - Practice - May 20th, 2011 [May 20th, 2011]
- Gene Doping: Super Athletes in 2008 Beijing Olympics - May 22nd, 2011 [May 22nd, 2011]
- Bacteria Cell - May 22nd, 2011 [May 22nd, 2011]
- Stem Cell Game 1 - Stem Cell Wrangler - May 24th, 2011 [May 24th, 2011]
- RSCI Don Margolis on Repair Stem Cells - May 30th, 2011 [May 30th, 2011]
- Mitosis - cell reproduction - June 1st, 2011 [June 1st, 2011]
- PROSTATE CANCER and stem cells.wmv - June 3rd, 2011 [June 3rd, 2011]
- Ah! So you can raise your power after all! - June 3rd, 2011 [June 3rd, 2011]
- BioEDEN European Stem Cell Bank - June 12th, 2011 [June 12th, 2011]
- Stem Cells Used to Grow Windpipes - June 15th, 2011 [June 15th, 2011]
- Stem Cell Game 3- Grow with the Flow - June 17th, 2011 [June 17th, 2011]
- Genetically modified kiwi - June 20th, 2011 [June 20th, 2011]
- Nurse Jackie Title Sequence - June 21st, 2011 [June 21st, 2011]
- Wrapsol Installation Video - Apple iPad - Original Front + Back - July 4th, 2011 [July 4th, 2011]
- Explore Health Don Margolis part2 - July 4th, 2011 [July 4th, 2011]
- Explore Health Carlos Lima and Christopher Reeve - July 10th, 2011 [July 10th, 2011]
- Oxidative stress: redox imbalance - July 14th, 2011 [July 14th, 2011]
- PROSTATE CANCER and stem cells - July 25th, 2011 [July 25th, 2011]
- Buy Priligy - July 28th, 2011 [July 28th, 2011]
- Stem Cell Therapy for Cerebral Palsy - Holly Catalano - August 2nd, 2011 [August 2nd, 2011]
- [Industry professional news channel itsTV] Weekly News Brief_0812 - August 20th, 2011 [August 20th, 2011]
- Sims 2 Mafia Story Part 7 - Farewell, Godfather/Stem Cell Medicine - August 30th, 2011 [August 30th, 2011]
- Doctors Use Stem Cells to Grow New Windpipes - August 31st, 2011 [August 31st, 2011]
- A New Way to Make Induced Pluripotent Stem Cells - September 5th, 2011 [September 5th, 2011]
- Stem Cell Research: Huntington's Disease - September 8th, 2011 [September 8th, 2011]
- Stem Cell Research: Huntington's Disease - September 8th, 2011 [September 8th, 2011]
- Regenerative Medicine and Applications of Stem Cell Research - September 9th, 2011 [September 9th, 2011]
- Genetically Modified T Cells Obliterate Chronic Lymphocytic Leukemia Tumors - September 9th, 2011 [September 9th, 2011]
- Stem Cell Treatment for Autism: Community Outreach Miami, Florida - May 2011 - September 10th, 2011 [September 10th, 2011]
- Susan Lim: Transplant cells, not organs - September 11th, 2011 [September 11th, 2011]
- Chiropractic Sports Medicine - September 11th, 2011 [September 11th, 2011]
- Living With and Managing Sickle Cell Disease - September 14th, 2011 [September 14th, 2011]
- WHO Finding Adds to Debate Over Mobile Phones, Brain Cancer - September 14th, 2011 [September 14th, 2011]
- Tionne "T-Boz" Watkins of TLC on Celebrity Medical Nightmares - September 16th, 2011 [September 16th, 2011]
- Tionne "T-Boz" Watkins of TLC on Celebrity Medical Nightmares - September 16th, 2011 [September 16th, 2011]
- Jello Biafra @ Rebellion 2011 - The Cell and Holiday in Cambodia - September 16th, 2011 [September 16th, 2011]
- CIRM Bridges: Training the Next Generation of Stem Cell Scientists - September 17th, 2011 [September 17th, 2011]
- David Kekich - Regenerative Medicine (Part 1/6) - September 17th, 2011 [September 17th, 2011]
- Coast To Coast AM - 9.6.2011 - 1/4 - US Collapse - September 18th, 2011 [September 18th, 2011]
- What Is Personalized Medicine? - September 21st, 2011 [September 21st, 2011]
- Stem Cells and a Brief Mention of Bacon - September 21st, 2011 [September 21st, 2011]
- Adult Stem Cell Sucess Stories - Laura Dominguez - September 23rd, 2011 [September 23rd, 2011]
- Is Regenerative Medicine Hype or Hope? - September 24th, 2011 [September 24th, 2011]
- How to Buy Bitcoin - by 'The Bitcoin Show' on OnlyOneTV.com - September 25th, 2011 [September 25th, 2011]
- How to Buy Bitcoin - by 'The Bitcoin Show' on OnlyOneTV.com - September 25th, 2011 [September 25th, 2011]
- Samsung Galaxy S2 Unboxing - September 25th, 2011 [September 25th, 2011]
- Finding Forest Planets (Brainstorm Ep8) - September 26th, 2011 [September 26th, 2011]
- iPhone 3GS mobile signal problem - The Computer Room Nottingham - September 30th, 2011 [September 30th, 2011]
- Mobile Devices' Location Tracking Raises Privacy Concerns - October 2nd, 2011 [October 2nd, 2011]
- Mobile Devices' Location Tracking Raises Privacy Concerns - October 2nd, 2011 [October 2nd, 2011]
- 21st Century Stem Cell Scientists: The CIRM Creativity Awards - October 4th, 2011 [October 4th, 2011]
- Towing An Iceberg to Africa, wait what? (Brainstorm Ep18) - October 4th, 2011 [October 4th, 2011]
- Need a New Liver? Then Just Print Yourself One - October 4th, 2011 [October 4th, 2011]
- The potential of amniotic fluid stem cells - October 4th, 2011 [October 4th, 2011]
- INCREDIBLE Nucleus Medical Media 2011 Demo - October 4th, 2011 [October 4th, 2011]
- Stem Cell Treatments for Autism: Community Outreach Miami, Florida - Juliana Ubinas - October 4th, 2011 [October 4th, 2011]
- Bruce Lipton: being a cell of Humanity - October 4th, 2011 [October 4th, 2011]
- Sensitiv Imago medical device - October 4th, 2011 [October 4th, 2011]
- New Lymphoma Drug SGN-35 - The Nebraska Medical Center - October 4th, 2011 [October 4th, 2011]
- Rockefeller University Press Conference 2011 Nobel Prize in Physiology or Medicine to Ralph Steinman - October 5th, 2011 [October 5th, 2011]
- Cerebral Palsy and Stem Cell Treatments - Tim's Testimonial - October 5th, 2011 [October 5th, 2011]
- Cerebral Palsy and Stem Cell Treatments - Tim's Testimonial - October 5th, 2011 [October 5th, 2011]
- Cerebral Palsy - October 5th, 2011 [October 5th, 2011]
- Stem Cells-Iran-08-28-2011 - October 5th, 2011 [October 5th, 2011]
- After Brain Study, New Questions About Mobile Phones - October 5th, 2011 [October 5th, 2011]
- Judy Roberson: Patient advocates drive stem cell scientists - October 5th, 2011 [October 5th, 2011]
- Geron's Embryonic Stem Cell Clinical Trial for Spinal Cord Injury - October 5th, 2011 [October 5th, 2011]
- Geron's Embryonic Stem Cell Clinical Trial for Spinal Cord Injury - October 5th, 2011 [October 5th, 2011]
- Dangers of Continued Use of Cell Phones-Pulse Sep 03, Part 2 - October 5th, 2011 [October 5th, 2011]
- 2011 Nobel Prize in Medicine - October 5th, 2011 [October 5th, 2011]